Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism KCC2 activators(solute carrier family 12 member 5 activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | IND Application | US | 21 Feb 2024 |